ARCHIVES

NEJM Papers, Interview With NCI’s Doroshow, Provide Justification For Regulatory Action on ESAs.

This article is from The Cancer Letter archive.

Vol. 33 No. 23 | June 15, 2007

Download PDF Visit The Full Archive

Related Articles

Therapeutic Modalities Improve Patient Quality of Life In Trials

February 27, 2004

In Brief: Pitot Appointed To Cancer Panel, Replacing Jako; Fisher, Wattenberg, Curtiss Lead Cancer Groups

May 29, 1992

In Brief: New Biomedical Research Panel To Organize Feb. 24-25, Discuss Mandate, Priorities

February 14, 1975

NCI R01 Payline Stays At 12th Percentile for FY07.

February 9, 2007

Studies Seek to Identify High-Risk Groups to Justify Mammography Screening at 40

May 4, 2012

M.D. Anderson, SWOG To Use Web-Based Software To Expand Access To Trials.

September 29, 2000